Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis. Luozzo LD, Salvato M, Frizzera F, Khalid K, et al. Arthritis Res Ther 2025;27:227.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luozzo LD, Salvato M, Frizzera F, Khalid K, et al. Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis. Arthritis Res Ther 2025;27:227.
PMID: 41419971